PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
$10.4 0.11 (1.069%)
Analysed PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) News Sources
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
05-10-2026
yahoo.com
Puma Biotechnology, Inc. Q2 2026 Earnings Call Summary
07-08-2026
moby.co
PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised
07-08-2026
yahoo.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03-09-2026
yahoo.com
Puma Biotechnology Inc (PBYI) (Q2 2026) Earnings Call Highlights: Debt-Free Status and Raised ...
07-08-2026
yahoo.com
Is Puma Biotechnology (PBYI) a Great Value Stock Right Now?
12-08-2026
yahoo.com
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript
14-08-2026
fool.com
Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference
09-09-2026
yahoo.com
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
17-09-2026
yahoo.com
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
18-09-2026
yahoo.com
What is the current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is $10.4.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is $0.11.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is 1.069%.
What is the most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is .
SEC-8K** Filing Available For PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.